Gibson S. Kibiki
Moshi, United Republic of Tanzania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
Saliva as an Alternative Matrix for Pharmacokinetic Research and Therapeutic Drug Monitoring of the Antituberculosis Drug Pyrazinamide.
Journal: Antibiotics (Basel, Switzerland)
Published: October 07, 2025
Intersecting social and environmental determinants of multidrug-resistant urinary tract infections in East Africa beyond antibiotic use.
Journal: Nature communications
Published: March 01, 2024
Treatment seeking behaviours, antibiotic use and relationships to multi-drug resistance: A study of urinary tract infection patients in Kenya, Tanzania and Uganda.
Journal: medRxiv : the preprint server for health sciences
Published: March 22, 2023
Treatment seeking behaviours, antibiotic use and relationships to multi-drug resistance: A study of urinary tract infection patients in Kenya, Tanzania and Uganda.
Journal: PLOS global public health
Published: March 20, 2023
Whole-genome sequencing of SARS-CoV-2 isolates from symptomatic and asymptomatic individuals in Tanzania.
Journal: Frontiers in medicine
Published: September 01, 2022
Unravelling patient pathways in the context of antibacterial resistance in East Africa.
Journal: BMC infectious diseases
Published: August 05, 2022
Effect of seven anti-tuberculosis treatment regimens on sputum microbiome: a retrospective analysis of the HIGHRIF study 2 and PanACEA MAMS-TB clinical trials.
Journal: The Lancet. Microbe
Published: July 27, 2022
Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: April 11, 2022
Use of a molecular bacterial load assay to distinguish between active TB and post-TB lung disease.
Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
Published: February 24, 2022
Pharmacodynamic biomarkers for quantifying the mycobacterial effect of high doses of rifampin in patients with rifampin-susceptible pulmonary tuberculosis.
Journal: International journal of mycobacteriology
Published: December 17, 2021
Tuberculosis Molecular Bacterial Load Assay Reveals Early Delayed Bacterial Killing in Patients With Relapse.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: December 13, 2021
Last Updated: 09/26/2026